Inventor · disambiguated record
Sylvie Laquerre
Also filed as: LAQUERRE SYLVIE · LAQUERRE SYLVIE G
21 granted patents·25 pending applications·144 citations·filing 2000–2024
93Inventor score
Top patents by PatentIndex Score
46 records- 0195US10869869B2Method of adjuvant cancer treatmentNOVARTIS AG·Filed 2019·Granted Dec 22, 2020·10 cites·3 claims
- 0295US6723316B2Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growthONYX PHARMA INC·Filed 2000·Granted Apr 20, 2004·71 cites·10 claims
- 0393US8952018B2Pharmaceutical combination of MEK inhibitor and B-Raf inhibitorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Feb 10, 2015·13 cites·5 claims
- 0491US8703781B2Pharmaceutical combination of MEK inhibitor and B-RAF inhibitorsDUMBLE MELISSA·Filed 2010·Granted Apr 22, 2014·14 cites·12 claims
- 0582US12448455B2Combination therapies with bispecific anti-EGFR/c-met antibodies and third generation EGFR tyrosine kinase inhibitorsJANSSEN BIOTECH INC·Filed 2023·Granted Oct 21, 2025·0 cites·23 claims
- 0681US7396679B2Oncolytic adenovirusONYX PHARMA INC·Filed 2002·Granted Jul 8, 2008·9 cites·16 claims
- 0781US7078030B2Oncolytic adenovirusONYX PHARMA INC·Filed 2003·Granted Jul 18, 2006·21 cites·9 claims
- 0881US2023330091A1Method of Adjuvant Cancer TreatmentNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0980US8642596B2Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena virusesDENG YIJUN·Filed 2005·Granted Feb 4, 2014·4 cites·15 claims
- 1071US2021060021A1Method of Adjuvant Cancer TreatmentNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1171US2023144627A1Cyclic Dinucleotides As Sting AgonistsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1270US2025101123A1Multispecific binding molecules comprising ltbr and edb binding domains and uses thereofCILAG GMBH INT·Filed 2024·Application pending·0 cites
- 1368US11879013B2Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation EGFR tyrosine kinase inhibitorsJANSSEN BIOTECH INC·Filed 2020·Granted Jan 23, 2024·0 cites·44 claims
- 1468US2015111904A1Pharmaceutical combination of mek inhibitor and b-raf inhibitorsGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 1566US7556955B2Nucleic acids encoding Candida kefyr cytosine deaminaseONYX PHARMA INC·Filed 2006·Granted Jul 7, 2009·0 cites·17 claims
- 1664US2024269203A1Oncolytic virus and uses thereofJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1763US9067873B2Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenavirusesKINETA FOUR LLC·Filed 2013·Granted Jun 30, 2015·0 cites·11 claims
- 1863US8796298B2Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancerDUMBLE MELISSA·Filed 2010·Granted Aug 5, 2014·1 cites·1 claims
- 1963US7141404B2Candida kefyr cytosine deaminaseONYX PHARMA INC·Filed 2003·Granted Nov 28, 2006·0 cites·8 claims
- 2063US2018338979A1Method of Adjuvant Cancer TreatmentNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2162US6660259B2Herpes simplex virus for treating unwanted hyperproliferative cell growthONYX PHARMA INC·Filed 2000·Granted Dec 9, 2003·1 cites·15 claims
- 2261US8962667B2Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesMICRODOSE THERAPEUTX INC·Filed 2014·Granted Feb 24, 2015·0 cites·30 claims
- 2361US2015216868A1Method of Adjuvant Cancer TreatmentGLAXOSMITHKLINE LLC·Filed 2013·Application pending·0 cites
- 2459US7414113B2Antibody that specifically binds to Candida kefyr Cytosine deaminaseONYX PHARMA INC·Filed 2006·Granted Aug 19, 2008·0 cites·8 claims
- 2559US2015094321A1CombinationGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 2659US2014303195A1CombinationGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 2759US2017202842A1Method of Adjuvant Cancer TreatmentNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2858US2014309243A1CombinationGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 2956US2018214451A1CombinationNOVARTIS AG·Filed 2018·Application pending·0 cites
- 3055US9402846B2Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancerNOVARTIS AG·Filed 2014·Granted Aug 2, 2016·0 cites·15 claims
- 3154US11472830B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2017·Granted Oct 18, 2022·0 cites·19 claims
- 3254US2021188990A1Multispecific binding molecules comprising ltbr and edb binding domains and uses thereofCILAG GMBH INT·Filed 2020·Application pending·0 cites
- 3354US2017065593A1CombinationNOVARTIS AG·Filed 2016·Application pending·0 cites
- 3451US12215160B2Treatment of patients having c-met exon 14 skipping mutationsJANSSEN BIOTECH INC·Filed 2021·Granted Feb 4, 2025·0 cites·47 claims
- 3551US2012283279A1CombinationGILMER TONA·Filed 2010·Application pending·0 cites
- 3650US2016008368A1CombinationNOVARTIS AG·Filed 2015·Application pending·0 cites
- 3750US2016143913A1CombinationNOVARTIS AG·Filed 2016·Application pending·0 cites
- 3848US2012283278A1CombinationDUMBLE MELISSA·Filed 2010·Application pending·0 cites
- 3947US11827708B2Proteins comprising HLA-G antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2021·Granted Nov 28, 2023·0 cites·28 claims
- 4045US8835450B2Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancerDUMBLE MELISSA·Filed 2010·Granted Sep 16, 2014·0 cites·4 claims
- 4142US2015147350A1Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK InhibitorGLAXOSMITHKLINE LLC·Filed 2012·Application pending·0 cites
- 4240US2012322817A1CombinationDUMBLE MELISSA·Filed 2010·Application pending·0 cites
- 4338US2013217710A1Methods for treating cancerALVES-AIVADO MANUEL CARLOS·Filed 2011·Application pending·0 cites
- 4430US2012202822A1CombinationBACHMAN KURTIS EARL·Filed 2010·Application pending·0 cites
- 4530US2013231347A1Method of treatment with braf inhibitorBLEAM MAUREEN·Filed 2011·Application pending·0 cites
- 4621US2012245180A1CombinationAUGER KURT R·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sylvie Laquerre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →